Youth Cannabis Use Linked to Higher Tobacco Risk
|
A UC San Diego study, led by Moores Member and Director of the Moores Biostatistics Shared Resource Karen Messer, PhD, has revealed that youth cannabis use increases the risk of tobacco use, which suggests that cannabis prevention is a strategy for tobacco control. Learn More»
|
The Many FACES of Lipid Research
|
|
|
UC San Diego researchers have unveiled FACES, a new imaging tool that reveals lipid movement inside cells with nanometer precision. Moores Member Neal Devaraj, PhD and his lab have made essential contributions to the project, which promises to advance understanding of lipid trafficking and cellular communication. Learn More»
|
MRD Remains a Mixed Bag in Blood Cancer Care
|
At the NCCN 2025 Congress, experts urged clearer standards for MRD testing. Indeed, Moores Member Thomas Kipps, MD, PhD has asserted the predictive value of MRD testing for chronic lymphocytic leukemia, while cautioning against overinterpretation due to sampling limits. Learn More»
|
|
|
New Imaging Technology to Boost Efficiency of Care
|
UC San Diego Health is partnering with GE HealthCare to deliver advanced imaging and AI tools systemwide, which will improve image quality, speed diagnoses, and streamline care for faster, more precise cancer treatments. Learn More»
|
|
|
UC San Diego Supercomputer Center Strengthening Research Network Security
|
The UC San Diego Supercomputer Center, in collaboration with Moores, is leading ROOTBEER (Routing Operations Observational Technology: Building to Enable Education and Research), an NSF-funded project to secure research networks, enhance data sharing, and accelerate scientific discoveries. Learn More»
|
|
|
2025 Revelle Medal Recipients Announced
|
This year’s recipients include Moores Members Edward Dennis, PhD, for his lipidomics research, and Tony Yaksh, PhD, for his research on spinal pain. Their contributions reflect decades of distinguished research, teaching, and service. Congratulations to both. Learn More»
|
| |
Moores Annual Scientific Retreat
|
This year’s retreat will be held Thursday, November 6, 2025 from 7:30 a.m. to 5:00 p.m. at Scripps Seaside Forum and will feature scientific presentations, a poster session, networking opportunities, and an afternoon keynote presentation.
RSVP Now» | Learn More» | View Agenda»
|
| UC San Diego Prostate Cancer Patient Summit
|
This event will be held Friday, January 30 (Community Think Tank) and Saturday, January 31 (Main Summit) 2026 and will feature national speakers, research updates, treatment advances, and sessions on patient care and caregiver support.
Register Now» | View Flyer»
|
|
|
FEATURED FUNDING OPPORTUNITIES |
View featured limited submission, federal, and non-federal grant and funding opportunities. |
ACTRI K12 Mentored Career Development Award
|
Equivalent to an NIH K23, K01, or K08, this award provides up to 3 years of support for early-career faculty members with $115,000/year toward salary, plus benefits, and $10,000/year in research and travel funds.
|
Application Deadline: November 21, 2025, 11:59 p.m. PST
Apply Now»
|
American Cancer Society (ACS) Institutional Research Grant 2026 |
Moores Member Michael Bouvet, MD, Member of the Local Committee of the ACS Institutional Research Grant (ACS-IRG-24-1317140-51-IRG), is pleased to announce the availability of seed money to stimulate cancer research projects of high merit among junior investigators at UC San Diego.
|
Application Deadline: November 10, 2025
Apply Now»
|
Hanna and Mark Gleiberman Head & Neck Cancer Center 2025 Research Pilot Project Grant Opportunity
|
This grant will fund research projects to improve curative therapy and the quality of care for head and neck cancer patients and their families. Project proposals may target any aspect of head and neck cancer care or head and neck and/or voice disease etiology, diagnosis, and therapy.
|
Application Deadline: November 14, 2025
Apply Now»
|
|
|
| The proteostasis network is a therapeutic target in acute myeloid leukemia |
Kentson Lam, MD, PhD (Hematologic Malignancies [HEM]), Helena Yu, MD (HEM), Leslie Crews, PhD (HEM), Edward Ball, MD (HEM), and Robert Signer, PhD (HEM)
|
|
|
| Clinical and family conversations regarding genetic testing: A case study of uncertainty management
|
Lourdes Martinez, PhD (Cancer Control)
|
|
|
| Image guided brachytherapy quality assurance on NRG GY017 investigating immunotherapy in addition to chemoradiation for locally advanced cervical cancer
|
Loren Mell, MD (Solid Tumor Therapeutics [STT]) and Jyoti Mayadev, MD (STT)
|
|
|
CLINICAL TRIALS OFFICE (CTO) |
|
|
D9727C00001: A Randomized, Double-blind, Placebo-controlled, Phase III Study of Adjuvant Saruparib (AZD5305) in Patients with BRCAm Localized High-Risk Prostate Cancer Receiving Radiotherapy with Androgen Deprivation Therapy (EvoPAR-Prostate02)
PI: Rana McKay, MD
NCT ID: NCT06952803
|
|
|
COMMUNITY OUTREACH AND ENGAGEMENT (COE)
|
COE Partners with New Creation Church for Hope Sunday |
On Sunday, October 26, 2025, COE joined the New Creation Church of San Diego for Hope Sunday, a community event to promote Breast Cancer Awareness and Domestic Violence Awareness Month, which delivered heartfelt stories; information about breast cancer risk factors, prevention, and early detection; and a spirit of hope and unity.
|
|
|
|
